Abstract
The altered gating of the mutant CFTR chloride channel cystic fibrosis (CF) may be corrected by small molecules called potentiators. We present a molecular scale simulation system for the discovery of ΔF508-CFTR soluble potentiators. Results report the design, ADME-Tox prediction, synthesis, solubility determination and in vitro biological evaluation of two 1,4-dihydropyridines (DHPs). Compound 1 shows a promising ADME-Tox profile and good potency.
Copyright © 2012 Elsevier Masson SAS. All rights reserved.
MeSH terms
-
Absorption
-
Animals
-
Calcium Channel Blockers / chemistry*
-
Calcium Channel Blockers / metabolism
-
Calcium Channel Blockers / pharmacology*
-
Calcium Channel Blockers / toxicity
-
Chemistry Techniques, Synthetic
-
Computational Biology*
-
Cystic Fibrosis Transmembrane Conductance Regulator / chemistry
-
Cystic Fibrosis Transmembrane Conductance Regulator / genetics
-
Cystic Fibrosis Transmembrane Conductance Regulator / metabolism*
-
Dihydropyridines / chemistry*
-
Dihydropyridines / metabolism
-
Dihydropyridines / pharmacology*
-
Dihydropyridines / toxicity
-
Drug Design*
-
Humans
-
Ligands
-
Models, Molecular
-
Mutation
-
Protein Conformation
-
Quantitative Structure-Activity Relationship
-
Rats
-
Solubility
Substances
-
Calcium Channel Blockers
-
Dihydropyridines
-
Ligands
-
Cystic Fibrosis Transmembrane Conductance Regulator
-
1,4-dihydropyridine